Rui Wang

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 7

Top Topics

Radical Prostatectomy

Crystal Structure

Top Venues

ACS pharmacology & translational science

AAPS PharmSciTech

Molecular cancer therapeutics

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

Satyanarayana Pochampally, Kelli L Hartman, Rui Wang, Jiaxing Wang, Mi-Kyung Yun, Keyur R Parmar, Hyunseo Park, Bernd Meibohm, Stephen W White, Wei Li, Duane D Miller
Design, Synthesis, and Biological Evaluation of Pyrimidine Dihydroquinoxalinone Derivatives as Tubulin Colchicine Site-Binding Agents That Displayed Potent Anticancer Activity Both In Vitro and In Vivo. ACS pharmacology & translational science 6 (4) (2023)
Satyanarayana Pochampally, Kelli L Hartman, Rui Wang, Jiaxing Wang, Mi-Kyung Yun, Keyur R Parmar, Hyunseo Park, Bernd Meibohm, Stephen W White, Wei Li, Duane D Miller
Design, Synthesis, and Biological Evaluation of Pyrimidine Dihydroquinoxalinone Derivatives as Tubulin Colchicine Site-Binding Agents That Displayed Potent Anticancer Activity Both In Vitro and In Vivo. ACS pharmacology & translational science 6 (4) (2023)
Hongbo Chen, Rui Wang, John-David McElderry
Discriminative Dissolution Method Development Through an aQbD Approach. AAPS PharmSciTech 24 (8) (2023)
Satyanarayana Pochampally, Kelli L Hartman, Rui Wang, Jiaxing Wang, Mi-Kyung Yun, Keyur R Parmar, Hyunseo Park, Bernd Meibohm, Stephen W White, Wei Li, Duane D Miller
Design, Synthesis, and Biological Evaluation of Pyrimidine Dihydroquinoxalinone Derivatives as Tubulin Colchicine Site-Binding Agents That Displayed Potent Anticancer Activity Both In Vitro and In Vivo. ACS pharmacology & translational science 6 (4) (2023)
Satyanarayana Pochampally, Kelli L Hartman, Rui Wang, Jiaxing Wang, Mi-Kyung Yun, Keyur R Parmar, Hyunseo Park, Bernd Meibohm, Stephen W White, Wei Li, Duane D Miller
Design, Synthesis, and Biological Evaluation of Pyrimidine Dihydroquinoxalinone Derivatives as Tubulin Colchicine Site-Binding Agents That Displayed Potent Anticancer Activity Both In Vitro and In Vivo. ACS pharmacology & translational science 6 (4) (2023)
Shanshan Deng, Raisa I Krutilina, Kelli L Hartman, Hao Chen, Deanna N Parke, Rui Wang, Sasha H Shafikhani, Dejian Ma, Pradeep B Lukka, Bernd Meibohm, Tiffany N Seagroves, Duane D Miller, Wei Li
Colchicine-Binding Site Agent CH-2-77 as a Potent Tubulin Inhibitor Suppressing Triple-Negative Breast Cancer. Molecular cancer therapeutics 21 (7) (2022)
Rajib Bhuniya, Xinrui Yuan, Longchuan Bai, Kathryn L Howie, Rui Wang, Wei Li, Frank Park, Chao-Yie Yang
Design, Synthesis, and Biological Evaluation of Apcin-Based CDC20 Inhibitors. ACS medicinal chemistry letters 13 (2) (2022)